Cargando…

Clinical Characteristics and Treatment Response With Checkpoint Inhibitors in Malignant Melanoma of the Vulva and Vagina

The aims of the study were to assess the clinical and histopathological characteristics of a comprehensive cohort of women with vulvovaginal melanoma (VVM) treated at our institution and to study the treatment response of checkpoint inhibitors in this patient cohort. MATERIALS AND METHODS: This is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wohlmuth, Christoph, Wohlmuth-Wieser, Iris, Laframboise, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Non-HPV Associated Neoplasia
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984764/ https://www.ncbi.nlm.nih.gov/pubmed/33252450 http://dx.doi.org/10.1097/LGT.0000000000000583

Ejemplares similares

Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients
por: Wohlmuth, Christoph, et al.
Publicado: (2019)

Vulvar Melanoma: Molecular Characteristics, Diagnosis, Surgical Management, and Medical Treatment
por: Wohlmuth, Christoph, et al.
Publicado: (2021)

Small Cell Carcinoma of the Vagina: First Systematic Review of Case Reports and Proposal of a Management Algorithm
por: Capote, Sira, et al.
Publicado: (2023)

Vulvar malignancies: an interdisciplinary perspective
por: Wohlmuth, Christoph, et al.
Publicado: (2019)

Gynecologic Malignancies in Children and Adolescents: How Common is the Uncommon?
por: Wohlmuth, Christoph, et al.
Publicado: (2021)

Desquamative Inflammatory Vaginitis and Plasma Cell Vulvitis Represent a Spectrum of Hemorrhagic Vestibulovaginitis
por: Song, Myriarm, et al.
Publicado: (2021)

Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan
por: Ogata, Dai, et al.
Publicado: (2023)

Learning on the Go: Assessing Knowledge Gained From Medical Podcasts Created for Vulvovaginal Disease Education
por: Dmytryshyn, Julia, et al.
Publicado: (2022)

The Impact of Psychosexual Counseling in Women With Lichen Sclerosus: A Randomized Controlled Trial
por: Vittrup, Gitte, et al.
Publicado: (2022)

Prevalence and Characterization of Undiagnosed Youths at Risk of Chlamydia trachomatis Infection: A Cross-sectional Study
por: Reyes-Lacalle, Azahara, et al.
Publicado: (2022)

The Clinicopathologic Challenge of Nonneoplastic Vulvar Acanthosis
por: Day, Tania, et al.
Publicado: (2022)

Comorbidity of Urogynecological and Gastrointestinal Disorders in Female Patients With Lichen Sclerosus
por: Söderlund, Jenni M., et al.
Publicado: (2023)

The Association Between Female Genital Schistosomiasis and Other Infections of the Lower Genital Tract in Adolescent Girls and Young Women: A Cross-Sectional Study in South Africa
por: Shukla, Jilna Dilip, et al.
Publicado: (2023)

Comorbidities in Male Patients With Lichen Sclerosus: A Case-Control Study
por: Hieta, Niina K., et al.
Publicado: (2023)

Nonsclerotic Lichen Sclerosus: Definition of a Concept and Pathologic Description
por: Day, Tania, et al.
Publicado: (2023)

Understanding Sexual and Gender Minority Populations and Organ-Based Screening Recommendations for Human Papillomavirus–Related Cancers
por: Jodry, Dominique, et al.
Publicado: (2023)

Tumors of the cervix, vagina, and vulva
por: Kurman, Robert J.
Publicado: (1992)

Social and psychological impact of HPV testing in cervical screening: a qualitative study
por: McCaffery, K, et al.
Publicado: (2006)

AN UPWARD TREND IN DNA P16INK4A METHYLATION PATTERN AND HIGH RISK HPV INFECTION ACCORDING TO THE SEVERITY OF THE CERVICAL LESION
por: Carestiato, Fernanda Nahoum, et al.
Publicado: (2013)

Engaging health plans to prioritize HPV vaccination and initiate at age 9
por: Foley, Shaylen, et al.
Publicado: (2023)

Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10
por: Kahn, Benjamin Z., et al.
Publicado: (2023)

HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US
por: Saxena, Kunal, et al.
Publicado: (2023)

Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review
por: Khan, Amal, et al.
Publicado: (2023)

Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017–2021)
por: Eun, Byung-Wook, et al.
Publicado: (2023)

Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series
por: Kajtezovic, Sidika, et al.
Publicado: (2023)

Parents’ willingness to vaccinate their daughters with human papillomavirus vaccine and associated factors in Debretabor town, Northwest Ethiopia: A community-based cross-sectional study
por: Aragaw, Getie Mihret, et al.
Publicado: (2023)

The association of initiating HPV vaccination at ages 9–10 years and up-to-date status among adolescents ages 13–17 years, 2016-2020
por: Minihan, Adair K., et al.
Publicado: (2023)

Implementing interventions to start HPV vaccination at age 9: Using the evidence we have
por: Brandt, Heather M., et al.
Publicado: (2023)

Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
por: O’Leary, Sonja C., et al.
Publicado: (2023)

HPV vaccine recommendations by age: A survey of providers in federally qualified health centers
por: Lake, Paige, et al.
Publicado: (2023)

Epidemiology of human papillomavirus on condyloma acuminatum in Shandong Province，China
por: Yuan, Haowen, et al.
Publicado: (2023)

Feminized vaccine? Parents’ attitudes toward HPV vaccination of adolescents in Poland: A representative study
por: Sobierajski, Tomasz, et al.
Publicado: (2023)

Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report
por: Achdiat, Pati Aji, et al.
Publicado: (2023)

Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
por: Goldstone, Stephen E.
Publicado: (2023)

Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs
por: Alsanafi, Mariam, et al.
Publicado: (2023)

Multi-level quality improvement strategies to optimize HPV vaccination starting at the 9-year well child visit: Success stories from two private pediatric clinics
por: Zorn, Sherri, et al.
Publicado: (2023)

Pediatric hematology and oncology physician and nurse practitioner views of the HPV vaccine and barriers to administration
por: Miller, Meagan E., et al.
Publicado: (2023)

HPV vaccine knowledge, attitudes, and practices among New York State medical providers, dentists, and pharmacists
por: Fernandes, Annlynn, et al.
Publicado: (2023)

HPV vaccine information, knowledge, attitude, and recommendation intention among male college students in China
por: Wu, Huamei, et al.
Publicado: (2023)

How to make effective HPV vaccine recommendations starting at age 9
por: Brewer, Noel T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kdgdkhhk2h0s9k6bincncmusch